Global High-Purity PLGA Polymers for Long-Acting Injectables Supply, Demand and Key Producers, 2026-2032
The global High-Purity PLGA Polymers for Long-Acting Injectables market size is expected to reach $ 169 million by 2032, rising at a market growth of 12.3% CAGR during the forecast period (2026-2032).
In 2025, global sales volume of high-purity pharmaceutical-grade PLGA polymers for injectable long-acting formulations reached approximately 4.8 metric tons, with an average selling price of around US$15,000/kg and a market size of approximately US$72 million. High-purity pharmaceutical-grade PLGA polymers for injectable long-acting formulations refer to biodegradable pharmaceutical polymers synthesized by copolymerization of lactide and glycolide monomers, featuring good biocompatibility, controllable degradation and sustained drug release performance. These products are typically supplied in a range of lactide/glycolide ratios, molecular weights, inherent viscosities and end-group structures to support different release profiles and formulation stability requirements. This market focuses on high-purity pharmaceutical-grade PLGA polymers used in injectable controlled-release drug delivery systems, including long-acting injectables, sustained-release microspheres, in-situ forming depot systems, biodegradable drug-eluting implants and nanoparticle drug delivery systems.
On the demand side, long-acting drug delivery has become an important approach for pharmaceutical companies to improve patient adherence, extend product life cycles and differentiate formulations. Therapeutic areas such as central nervous system disorders, endocrinology, oncology supportive care, addiction treatment and chronic disease management all create demand for injectable controlled-release products. This is driving pharmaceutical companies and formulation CDMOs to procure high-purity, customizable and registration-ready PLGA materials. Compared with medical device-grade or research-grade PLGA, injectable pharmaceutical-grade PLGA requires stricter control over purity, molecular weight distribution, end-group chemistry, residual monomers, residual solvents and endotoxin levels, supporting its premium pricing and strong customer stickiness.
From a competitive perspective, the global high-end pharmaceutical-grade PLGA market remains concentrated among a limited number of suppliers in Europe, the United States and Japan. Companies such as Evonik, Corbion, Ashland, SEQENS and Mitsui Chemicals hold advantages in product portfolios, quality systems, regulatory support and customer validation. Chinese suppliers are entering the market through pharmaceutical excipient registration, injectable-grade product development and domestic substitution opportunities, but still need to strengthen their capabilities in batch consistency, scale-up quality control, international regulatory support and commercial customer validation. Future competition is expected to focus less on price and more on regulatory documentation, customization capability, supply reliability and deep integration with formulation development projects.
Overall, this is a high-quality niche market with strong research value and solid customer interest. The global market size is estimated at approximately US$72 million in 2025 and is expected to reach around US$82 million in 2026, with a projected CAGR of about 12.6% from 2026 to 2032. Given the long development cycle of long-acting injectables, the high cost of material replacement and the limited number of qualified suppliers, this market is not a large-volume commodity segment, but it is well suited as a focused research topic within high-end pharmaceutical excipients, complex formulation upstream materials and drug delivery materials.
This report studies the global High-Purity PLGA Polymers for Long-Acting Injectables production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for High-Purity PLGA Polymers for Long-Acting Injectables and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of High-Purity PLGA Polymers for Long-Acting Injectables that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global High-Purity PLGA Polymers for Long-Acting Injectables total production and demand, 2021-2032, (Tons)
Global High-Purity PLGA Polymers for Long-Acting Injectables total production value, 2021-2032, (USD Million)
Global High-Purity PLGA Polymers for Long-Acting Injectables production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global High-Purity PLGA Polymers for Long-Acting Injectables consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: High-Purity PLGA Polymers for Long-Acting Injectables domestic production, consumption, key domestic manufacturers and share
Global High-Purity PLGA Polymers for Long-Acting Injectables production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global High-Purity PLGA Polymers for Long-Acting Injectables production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global High-Purity PLGA Polymers for Long-Acting Injectables production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global High-Purity PLGA Polymers for Long-Acting Injectables market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik Industries AG, Corbion N.V., Ashland Inc., SEQENS, Mitsui Chemicals, Inc., Nanjing Well Pharmaceutical Group Co., Ltd., Guangzhou DiQi Pharmaceuticals Co., Ltd., Nomisma Healthcare Pvt. Ltd., Zhejiang Langhua Pharmaceutical Co., Ltd., Hunan Er-Kang Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World High-Purity PLGA Polymers for Long-Acting Injectables market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global High-Purity PLGA Polymers for Long-Acting Injectables Market, By Region:
1. How big is the global High-Purity PLGA Polymers for Long-Acting Injectables market?
2. What is the demand of the global High-Purity PLGA Polymers for Long-Acting Injectables market?
3. What is the year over year growth of the global High-Purity PLGA Polymers for Long-Acting Injectables market?
4. What is the production and production value of the global High-Purity PLGA Polymers for Long-Acting Injectables market?
5. Who are the key producers in the global High-Purity PLGA Polymers for Long-Acting Injectables market?
6. What are the growth factors driving the market demand?
In 2025, global sales volume of high-purity pharmaceutical-grade PLGA polymers for injectable long-acting formulations reached approximately 4.8 metric tons, with an average selling price of around US$15,000/kg and a market size of approximately US$72 million. High-purity pharmaceutical-grade PLGA polymers for injectable long-acting formulations refer to biodegradable pharmaceutical polymers synthesized by copolymerization of lactide and glycolide monomers, featuring good biocompatibility, controllable degradation and sustained drug release performance. These products are typically supplied in a range of lactide/glycolide ratios, molecular weights, inherent viscosities and end-group structures to support different release profiles and formulation stability requirements. This market focuses on high-purity pharmaceutical-grade PLGA polymers used in injectable controlled-release drug delivery systems, including long-acting injectables, sustained-release microspheres, in-situ forming depot systems, biodegradable drug-eluting implants and nanoparticle drug delivery systems.
On the demand side, long-acting drug delivery has become an important approach for pharmaceutical companies to improve patient adherence, extend product life cycles and differentiate formulations. Therapeutic areas such as central nervous system disorders, endocrinology, oncology supportive care, addiction treatment and chronic disease management all create demand for injectable controlled-release products. This is driving pharmaceutical companies and formulation CDMOs to procure high-purity, customizable and registration-ready PLGA materials. Compared with medical device-grade or research-grade PLGA, injectable pharmaceutical-grade PLGA requires stricter control over purity, molecular weight distribution, end-group chemistry, residual monomers, residual solvents and endotoxin levels, supporting its premium pricing and strong customer stickiness.
From a competitive perspective, the global high-end pharmaceutical-grade PLGA market remains concentrated among a limited number of suppliers in Europe, the United States and Japan. Companies such as Evonik, Corbion, Ashland, SEQENS and Mitsui Chemicals hold advantages in product portfolios, quality systems, regulatory support and customer validation. Chinese suppliers are entering the market through pharmaceutical excipient registration, injectable-grade product development and domestic substitution opportunities, but still need to strengthen their capabilities in batch consistency, scale-up quality control, international regulatory support and commercial customer validation. Future competition is expected to focus less on price and more on regulatory documentation, customization capability, supply reliability and deep integration with formulation development projects.
Overall, this is a high-quality niche market with strong research value and solid customer interest. The global market size is estimated at approximately US$72 million in 2025 and is expected to reach around US$82 million in 2026, with a projected CAGR of about 12.6% from 2026 to 2032. Given the long development cycle of long-acting injectables, the high cost of material replacement and the limited number of qualified suppliers, this market is not a large-volume commodity segment, but it is well suited as a focused research topic within high-end pharmaceutical excipients, complex formulation upstream materials and drug delivery materials.
This report studies the global High-Purity PLGA Polymers for Long-Acting Injectables production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for High-Purity PLGA Polymers for Long-Acting Injectables and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of High-Purity PLGA Polymers for Long-Acting Injectables that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global High-Purity PLGA Polymers for Long-Acting Injectables total production and demand, 2021-2032, (Tons)
Global High-Purity PLGA Polymers for Long-Acting Injectables total production value, 2021-2032, (USD Million)
Global High-Purity PLGA Polymers for Long-Acting Injectables production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global High-Purity PLGA Polymers for Long-Acting Injectables consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: High-Purity PLGA Polymers for Long-Acting Injectables domestic production, consumption, key domestic manufacturers and share
Global High-Purity PLGA Polymers for Long-Acting Injectables production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global High-Purity PLGA Polymers for Long-Acting Injectables production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global High-Purity PLGA Polymers for Long-Acting Injectables production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global High-Purity PLGA Polymers for Long-Acting Injectables market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik Industries AG, Corbion N.V., Ashland Inc., SEQENS, Mitsui Chemicals, Inc., Nanjing Well Pharmaceutical Group Co., Ltd., Guangzhou DiQi Pharmaceuticals Co., Ltd., Nomisma Healthcare Pvt. Ltd., Zhejiang Langhua Pharmaceutical Co., Ltd., Hunan Er-Kang Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World High-Purity PLGA Polymers for Long-Acting Injectables market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global High-Purity PLGA Polymers for Long-Acting Injectables Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- PLGA 50:50
- PLGA 75:25
- PLGA 85:15
- Other Ratios and Customized PLGA
- Pharmaceutical Companies and Marketing Authorization Holders
- Formulation CDMOs and Drug Delivery Development Service Providers
- Research Institutions and Translational R&D Platforms
- Other End Users
- Sustained-release Microspheres
- In-situ Forming Depot Systems
- Biodegradable Drug-eluting Implants
- Nanoparticle Drug Delivery Systems
- Other Parenteral Controlled-release Applications
- Evonik Industries AG
- Corbion N.V.
- Ashland Inc.
- SEQENS
- Mitsui Chemicals, Inc.
- Nanjing Well Pharmaceutical Group Co., Ltd.
- Guangzhou DiQi Pharmaceuticals Co., Ltd.
- Nomisma Healthcare Pvt. Ltd.
- Zhejiang Langhua Pharmaceutical Co., Ltd.
- Hunan Er-Kang Pharmaceutical Co., Ltd.
- Shanghai Libaimei Biotechnology Co., Ltd.
- Zhejiang Bangyao Biomaterials Co., Ltd.
1. How big is the global High-Purity PLGA Polymers for Long-Acting Injectables market?
2. What is the demand of the global High-Purity PLGA Polymers for Long-Acting Injectables market?
3. What is the year over year growth of the global High-Purity PLGA Polymers for Long-Acting Injectables market?
4. What is the production and production value of the global High-Purity PLGA Polymers for Long-Acting Injectables market?
5. Who are the key producers in the global High-Purity PLGA Polymers for Long-Acting Injectables market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 High-Purity PLGA Polymers for Long-Acting Injectables Introduction
1.2 World High-Purity PLGA Polymers for Long-Acting Injectables Supply & Forecast
1.2.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021 & 2025 & 2032)
1.2.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.2.3 World High-Purity PLGA Polymers for Long-Acting Injectables Pricing Trends (2021-2032)
1.3 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (Based on Production Site)
1.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2021-2032)
1.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2021-2032)
1.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Region (2021-2032)
1.3.4 North America High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.5 Europe High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.6 China High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.7 Japan High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.8 India High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.9 Southeast Asia High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 High-Purity PLGA Polymers for Long-Acting Injectables Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 High-Purity PLGA Polymers for Long-Acting Injectables Major Market Trends
2 DEMAND SUMMARY
2.1 World High-Purity PLGA Polymers for Long-Acting Injectables Demand (2021-2032)
2.2 World High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region
2.2.1 World High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region (2021-2026)
2.2.2 World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Forecast by Region (2027-2032)
2.3 United States High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.4 China High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.5 Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.6 Japan High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.7 South Korea High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.8 ASEAN High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.9 India High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Manufacturer (2021-2026)
3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Manufacturer (2021-2026)
3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Manufacturer (2021-2026)
3.4 High-Purity PLGA Polymers for Long-Acting Injectables Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for High-Purity PLGA Polymers for Long-Acting Injectables in 2025
3.5.3 Global Concentration Ratios (CR8) for High-Purity PLGA Polymers for Long-Acting Injectables in 2025
3.6 High-Purity PLGA Polymers for Long-Acting Injectables Market: Overall Company Footprint Analysis
3.6.1 High-Purity PLGA Polymers for Long-Acting Injectables Market: Region Footprint
3.6.2 High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Type Footprint
3.6.3 High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison
4.1.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison
4.2.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison
4.3.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers and Market Share, 2021-2026
4.4.1 United States Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021-2026)
4.4.3 United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026)
4.5 China Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers and Market Share
4.5.1 China Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021-2026)
4.5.3 China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026)
4.6 Rest of World Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 PLGA 50:50
5.2.2 PLGA 75:25
5.2.3 PLGA 85:15
5.2.4 Other Ratios and Customized PLGA
5.3 Market Segment by Type
5.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2021-2032)
5.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2021-2032)
5.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY END USER
6.1 World High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Pharmaceutical Companies and Marketing Authorization Holders
6.2.2 Formulation CDMOs and Drug Delivery Development Service Providers
6.2.3 Research Institutions and Translational R&D Platforms
6.2.4 Other End Users
6.3 Market Segment by End User
6.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production by End User (2021-2032)
6.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User (2021-2032)
6.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Sustained-release Microspheres
7.2.2 In-situ Forming Depot Systems
7.2.3 Biodegradable Drug-eluting Implants
7.2.4 Nanoparticle Drug Delivery Systems
7.2.5 Other Parenteral Controlled-release Applications
7.3 Market Segment by Application
7.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2021-2032)
7.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2021-2032)
7.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Evonik Industries AG
8.1.1 Evonik Industries AG Details
8.1.2 Evonik Industries AG Major Business
8.1.3 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.1.4 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Evonik Industries AG Recent Developments/Updates
8.1.6 Evonik Industries AG Competitive Strengths & Weaknesses
8.2 Corbion N.V.
8.2.1 Corbion N.V. Details
8.2.2 Corbion N.V. Major Business
8.2.3 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.2.4 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Corbion N.V. Recent Developments/Updates
8.2.6 Corbion N.V. Competitive Strengths & Weaknesses
8.3 Ashland Inc.
8.3.1 Ashland Inc. Details
8.3.2 Ashland Inc. Major Business
8.3.3 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.3.4 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Ashland Inc. Recent Developments/Updates
8.3.6 Ashland Inc. Competitive Strengths & Weaknesses
8.4 SEQENS
8.4.1 SEQENS Details
8.4.2 SEQENS Major Business
8.4.3 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.4.4 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 SEQENS Recent Developments/Updates
8.4.6 SEQENS Competitive Strengths & Weaknesses
8.5 Mitsui Chemicals, Inc.
8.5.1 Mitsui Chemicals, Inc. Details
8.5.2 Mitsui Chemicals, Inc. Major Business
8.5.3 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.5.4 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Mitsui Chemicals, Inc. Recent Developments/Updates
8.5.6 Mitsui Chemicals, Inc. Competitive Strengths & Weaknesses
8.6 Nanjing Well Pharmaceutical Group Co., Ltd.
8.6.1 Nanjing Well Pharmaceutical Group Co., Ltd. Details
8.6.2 Nanjing Well Pharmaceutical Group Co., Ltd. Major Business
8.6.3 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.6.4 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Nanjing Well Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.6.6 Nanjing Well Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.7 Guangzhou DiQi Pharmaceuticals Co., Ltd.
8.7.1 Guangzhou DiQi Pharmaceuticals Co., Ltd. Details
8.7.2 Guangzhou DiQi Pharmaceuticals Co., Ltd. Major Business
8.7.3 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.7.4 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Developments/Updates
8.7.6 Guangzhou DiQi Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
8.8 Nomisma Healthcare Pvt. Ltd.
8.8.1 Nomisma Healthcare Pvt. Ltd. Details
8.8.2 Nomisma Healthcare Pvt. Ltd. Major Business
8.8.3 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.8.4 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Nomisma Healthcare Pvt. Ltd. Recent Developments/Updates
8.8.6 Nomisma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
8.9 Zhejiang Langhua Pharmaceutical Co., Ltd.
8.9.1 Zhejiang Langhua Pharmaceutical Co., Ltd. Details
8.9.2 Zhejiang Langhua Pharmaceutical Co., Ltd. Major Business
8.9.3 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.9.4 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Developments/Updates
8.9.6 Zhejiang Langhua Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.10 Hunan Er-Kang Pharmaceutical Co., Ltd.
8.10.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Details
8.10.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Major Business
8.10.3 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.10.4 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments/Updates
8.10.6 Hunan Er-Kang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.11 Shanghai Libaimei Biotechnology Co., Ltd.
8.11.1 Shanghai Libaimei Biotechnology Co., Ltd. Details
8.11.2 Shanghai Libaimei Biotechnology Co., Ltd. Major Business
8.11.3 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.11.4 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Shanghai Libaimei Biotechnology Co., Ltd. Recent Developments/Updates
8.11.6 Shanghai Libaimei Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.12 Zhejiang Bangyao Biomaterials Co., Ltd.
8.12.1 Zhejiang Bangyao Biomaterials Co., Ltd. Details
8.12.2 Zhejiang Bangyao Biomaterials Co., Ltd. Major Business
8.12.3 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.12.4 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Zhejiang Bangyao Biomaterials Co., Ltd. Recent Developments/Updates
8.12.6 Zhejiang Bangyao Biomaterials Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 High-Purity PLGA Polymers for Long-Acting Injectables Industry Chain
9.2 High-Purity PLGA Polymers for Long-Acting Injectables Upstream Analysis
9.2.1 High-Purity PLGA Polymers for Long-Acting Injectables Core Raw Materials
9.2.2 Main Manufacturers of High-Purity PLGA Polymers for Long-Acting Injectables Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 High-Purity PLGA Polymers for Long-Acting Injectables Production Mode
9.6 High-Purity PLGA Polymers for Long-Acting Injectables Procurement Model
9.7 High-Purity PLGA Polymers for Long-Acting Injectables Industry Sales Model and Sales Channels
9.7.1 High-Purity PLGA Polymers for Long-Acting Injectables Sales Model
9.7.2 High-Purity PLGA Polymers for Long-Acting Injectables Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 High-Purity PLGA Polymers for Long-Acting Injectables Introduction
1.2 World High-Purity PLGA Polymers for Long-Acting Injectables Supply & Forecast
1.2.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021 & 2025 & 2032)
1.2.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.2.3 World High-Purity PLGA Polymers for Long-Acting Injectables Pricing Trends (2021-2032)
1.3 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (Based on Production Site)
1.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2021-2032)
1.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2021-2032)
1.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Region (2021-2032)
1.3.4 North America High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.5 Europe High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.6 China High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.7 Japan High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.8 India High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.3.9 Southeast Asia High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 High-Purity PLGA Polymers for Long-Acting Injectables Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 High-Purity PLGA Polymers for Long-Acting Injectables Major Market Trends
2 DEMAND SUMMARY
2.1 World High-Purity PLGA Polymers for Long-Acting Injectables Demand (2021-2032)
2.2 World High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region
2.2.1 World High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region (2021-2026)
2.2.2 World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Forecast by Region (2027-2032)
2.3 United States High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.4 China High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.5 Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.6 Japan High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.7 South Korea High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.8 ASEAN High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
2.9 India High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Manufacturer (2021-2026)
3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Manufacturer (2021-2026)
3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Manufacturer (2021-2026)
3.4 High-Purity PLGA Polymers for Long-Acting Injectables Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for High-Purity PLGA Polymers for Long-Acting Injectables in 2025
3.5.3 Global Concentration Ratios (CR8) for High-Purity PLGA Polymers for Long-Acting Injectables in 2025
3.6 High-Purity PLGA Polymers for Long-Acting Injectables Market: Overall Company Footprint Analysis
3.6.1 High-Purity PLGA Polymers for Long-Acting Injectables Market: Region Footprint
3.6.2 High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Type Footprint
3.6.3 High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison
4.1.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison
4.2.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison
4.3.1 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers and Market Share, 2021-2026
4.4.1 United States Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021-2026)
4.4.3 United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026)
4.5 China Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers and Market Share
4.5.1 China Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021-2026)
4.5.3 China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026)
4.6 Rest of World Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 PLGA 50:50
5.2.2 PLGA 75:25
5.2.3 PLGA 85:15
5.2.4 Other Ratios and Customized PLGA
5.3 Market Segment by Type
5.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2021-2032)
5.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2021-2032)
5.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY END USER
6.1 World High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Pharmaceutical Companies and Marketing Authorization Holders
6.2.2 Formulation CDMOs and Drug Delivery Development Service Providers
6.2.3 Research Institutions and Translational R&D Platforms
6.2.4 Other End Users
6.3 Market Segment by End User
6.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production by End User (2021-2032)
6.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User (2021-2032)
6.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World High-Purity PLGA Polymers for Long-Acting Injectables Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Sustained-release Microspheres
7.2.2 In-situ Forming Depot Systems
7.2.3 Biodegradable Drug-eluting Implants
7.2.4 Nanoparticle Drug Delivery Systems
7.2.5 Other Parenteral Controlled-release Applications
7.3 Market Segment by Application
7.3.1 World High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2021-2032)
7.3.2 World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2021-2032)
7.3.3 World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Evonik Industries AG
8.1.1 Evonik Industries AG Details
8.1.2 Evonik Industries AG Major Business
8.1.3 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.1.4 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Evonik Industries AG Recent Developments/Updates
8.1.6 Evonik Industries AG Competitive Strengths & Weaknesses
8.2 Corbion N.V.
8.2.1 Corbion N.V. Details
8.2.2 Corbion N.V. Major Business
8.2.3 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.2.4 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Corbion N.V. Recent Developments/Updates
8.2.6 Corbion N.V. Competitive Strengths & Weaknesses
8.3 Ashland Inc.
8.3.1 Ashland Inc. Details
8.3.2 Ashland Inc. Major Business
8.3.3 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.3.4 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Ashland Inc. Recent Developments/Updates
8.3.6 Ashland Inc. Competitive Strengths & Weaknesses
8.4 SEQENS
8.4.1 SEQENS Details
8.4.2 SEQENS Major Business
8.4.3 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.4.4 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 SEQENS Recent Developments/Updates
8.4.6 SEQENS Competitive Strengths & Weaknesses
8.5 Mitsui Chemicals, Inc.
8.5.1 Mitsui Chemicals, Inc. Details
8.5.2 Mitsui Chemicals, Inc. Major Business
8.5.3 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.5.4 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Mitsui Chemicals, Inc. Recent Developments/Updates
8.5.6 Mitsui Chemicals, Inc. Competitive Strengths & Weaknesses
8.6 Nanjing Well Pharmaceutical Group Co., Ltd.
8.6.1 Nanjing Well Pharmaceutical Group Co., Ltd. Details
8.6.2 Nanjing Well Pharmaceutical Group Co., Ltd. Major Business
8.6.3 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.6.4 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Nanjing Well Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.6.6 Nanjing Well Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.7 Guangzhou DiQi Pharmaceuticals Co., Ltd.
8.7.1 Guangzhou DiQi Pharmaceuticals Co., Ltd. Details
8.7.2 Guangzhou DiQi Pharmaceuticals Co., Ltd. Major Business
8.7.3 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.7.4 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Developments/Updates
8.7.6 Guangzhou DiQi Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
8.8 Nomisma Healthcare Pvt. Ltd.
8.8.1 Nomisma Healthcare Pvt. Ltd. Details
8.8.2 Nomisma Healthcare Pvt. Ltd. Major Business
8.8.3 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.8.4 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Nomisma Healthcare Pvt. Ltd. Recent Developments/Updates
8.8.6 Nomisma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
8.9 Zhejiang Langhua Pharmaceutical Co., Ltd.
8.9.1 Zhejiang Langhua Pharmaceutical Co., Ltd. Details
8.9.2 Zhejiang Langhua Pharmaceutical Co., Ltd. Major Business
8.9.3 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.9.4 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Developments/Updates
8.9.6 Zhejiang Langhua Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.10 Hunan Er-Kang Pharmaceutical Co., Ltd.
8.10.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Details
8.10.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Major Business
8.10.3 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.10.4 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments/Updates
8.10.6 Hunan Er-Kang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.11 Shanghai Libaimei Biotechnology Co., Ltd.
8.11.1 Shanghai Libaimei Biotechnology Co., Ltd. Details
8.11.2 Shanghai Libaimei Biotechnology Co., Ltd. Major Business
8.11.3 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.11.4 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Shanghai Libaimei Biotechnology Co., Ltd. Recent Developments/Updates
8.11.6 Shanghai Libaimei Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.12 Zhejiang Bangyao Biomaterials Co., Ltd.
8.12.1 Zhejiang Bangyao Biomaterials Co., Ltd. Details
8.12.2 Zhejiang Bangyao Biomaterials Co., Ltd. Major Business
8.12.3 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
8.12.4 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Zhejiang Bangyao Biomaterials Co., Ltd. Recent Developments/Updates
8.12.6 Zhejiang Bangyao Biomaterials Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 High-Purity PLGA Polymers for Long-Acting Injectables Industry Chain
9.2 High-Purity PLGA Polymers for Long-Acting Injectables Upstream Analysis
9.2.1 High-Purity PLGA Polymers for Long-Acting Injectables Core Raw Materials
9.2.2 Main Manufacturers of High-Purity PLGA Polymers for Long-Acting Injectables Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 High-Purity PLGA Polymers for Long-Acting Injectables Production Mode
9.6 High-Purity PLGA Polymers for Long-Acting Injectables Procurement Model
9.7 High-Purity PLGA Polymers for Long-Acting Injectables Industry Sales Model and Sales Channels
9.7.1 High-Purity PLGA Polymers for Long-Acting Injectables Sales Model
9.7.2 High-Purity PLGA Polymers for Long-Acting Injectables Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2021-2026) & (USD Million)
Table 3. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2027-2032) & (USD Million)
Table 4. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region (2021-2026)
Table 5. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region (2027-2032)
Table 6. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2021-2026) & (Tons)
Table 7. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2027-2032) & (Tons)
Table 8. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2026)
Table 9. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2027-2032)
Table 10. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Region (2021-2026) & (US$/kg)
Table 11. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Region (2027-2032) & (US$/kg)
Table 12. High-Purity PLGA Polymers for Long-Acting Injectables Major Market Trends
Table 13. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region (2021-2026) & (Tons)
Table 15. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key High-Purity PLGA Polymers for Long-Acting Injectables Producers in 2025
Table 18. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key High-Purity PLGA Polymers for Long-Acting Injectables Producers in 2025
Table 20. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global High-Purity PLGA Polymers for Long-Acting Injectables Company Evaluation Quadrant
Table 22. World High-Purity PLGA Polymers for Long-Acting Injectables Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and High-Purity PLGA Polymers for Long-Acting Injectables Production Site of Key Manufacturer
Table 24. High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Type Footprint
Table 25. High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Application Footprint
Table 26. High-Purity PLGA Polymers for Long-Acting Injectables Competitive Factors
Table 27. High-Purity PLGA Polymers for Long-Acting Injectables New Entrant and Capacity Expansion Plans
Table 28. High-Purity PLGA Polymers for Long-Acting Injectables Mergers & Acquisitions Activity
Table 29. United States VS China High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share (2021-2026)
Table 37. China Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share (2021-2026)
Table 42. Rest of World Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share (2021-2026)
Table 47. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2021-2026) & (Tons)
Table 49. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2027-2032) & (Tons)
Table 50. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2021-2026) & (USD Million)
Table 51. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2027-2032) & (USD Million)
Table 52. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2021-2026) & (US$/kg)
Table 53. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2027-2032) & (US$/kg)
Table 54. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 55. World High-Purity PLGA Polymers for Long-Acting Injectables Production by End User (2021-2026) & (Tons)
Table 56. World High-Purity PLGA Polymers for Long-Acting Injectables Production by End User (2027-2032) & (Tons)
Table 57. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User (2021-2026) & (USD Million)
Table 58. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User (2027-2032) & (USD Million)
Table 59. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2021-2026) & (US$/kg)
Table 60. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2027-2032) & (US$/kg)
Table 61. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2021-2026) & (Tons)
Table 63. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2027-2032) & (Tons)
Table 64. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2021-2026) & (USD Million)
Table 65. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2027-2032) & (USD Million)
Table 66. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2021-2026) & (US$/kg)
Table 67. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2027-2032) & (US$/kg)
Table 68. Evonik Industries AG Basic Information, Manufacturing Base and Competitors
Table 69. Evonik Industries AG Major Business
Table 70. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 71. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Evonik Industries AG Recent Developments/Updates
Table 73. Evonik Industries AG Competitive Strengths & Weaknesses
Table 74. Corbion N.V. Basic Information, Manufacturing Base and Competitors
Table 75. Corbion N.V. Major Business
Table 76. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 77. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Corbion N.V. Recent Developments/Updates
Table 79. Corbion N.V. Competitive Strengths & Weaknesses
Table 80. Ashland Inc. Basic Information, Manufacturing Base and Competitors
Table 81. Ashland Inc. Major Business
Table 82. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 83. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Ashland Inc. Recent Developments/Updates
Table 85. Ashland Inc. Competitive Strengths & Weaknesses
Table 86. SEQENS Basic Information, Manufacturing Base and Competitors
Table 87. SEQENS Major Business
Table 88. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 89. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. SEQENS Recent Developments/Updates
Table 91. SEQENS Competitive Strengths & Weaknesses
Table 92. Mitsui Chemicals, Inc. Basic Information, Manufacturing Base and Competitors
Table 93. Mitsui Chemicals, Inc. Major Business
Table 94. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 95. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Mitsui Chemicals, Inc. Recent Developments/Updates
Table 97. Mitsui Chemicals, Inc. Competitive Strengths & Weaknesses
Table 98. Nanjing Well Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 99. Nanjing Well Pharmaceutical Group Co., Ltd. Major Business
Table 100. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 101. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Nanjing Well Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 103. Nanjing Well Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 104. Guangzhou DiQi Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 105. Guangzhou DiQi Pharmaceuticals Co., Ltd. Major Business
Table 106. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 107. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 109. Guangzhou DiQi Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 110. Nomisma Healthcare Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 111. Nomisma Healthcare Pvt. Ltd. Major Business
Table 112. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 113. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Nomisma Healthcare Pvt. Ltd. Recent Developments/Updates
Table 115. Nomisma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
Table 116. Zhejiang Langhua Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 117. Zhejiang Langhua Pharmaceutical Co., Ltd. Major Business
Table 118. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 119. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 121. Zhejiang Langhua Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 122. Hunan Er-Kang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 123. Hunan Er-Kang Pharmaceutical Co., Ltd. Major Business
Table 124. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 125. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 127. Hunan Er-Kang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 128. Shanghai Libaimei Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 129. Shanghai Libaimei Biotechnology Co., Ltd. Major Business
Table 130. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 131. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Shanghai Libaimei Biotechnology Co., Ltd. Recent Developments/Updates
Table 133. Shanghai Libaimei Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 134. Zhejiang Bangyao Biomaterials Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 135. Zhejiang Bangyao Biomaterials Co., Ltd. Major Business
Table 136. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 137. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Zhejiang Bangyao Biomaterials Co., Ltd. Recent Developments/Updates
Table 139. Zhejiang Bangyao Biomaterials Co., Ltd. Competitive Strengths & Weaknesses
Table 140. Global Key Players of High-Purity PLGA Polymers for Long-Acting Injectables Upstream (Raw Materials)
Table 141. Global High-Purity PLGA Polymers for Long-Acting Injectables Typical Customers
Table 142. High-Purity PLGA Polymers for Long-Acting Injectables Typical Distributors
Table 1. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2021-2026) & (USD Million)
Table 3. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2027-2032) & (USD Million)
Table 4. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region (2021-2026)
Table 5. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region (2027-2032)
Table 6. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2021-2026) & (Tons)
Table 7. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2027-2032) & (Tons)
Table 8. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2026)
Table 9. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2027-2032)
Table 10. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Region (2021-2026) & (US$/kg)
Table 11. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Region (2027-2032) & (US$/kg)
Table 12. High-Purity PLGA Polymers for Long-Acting Injectables Major Market Trends
Table 13. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region (2021-2026) & (Tons)
Table 15. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key High-Purity PLGA Polymers for Long-Acting Injectables Producers in 2025
Table 18. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key High-Purity PLGA Polymers for Long-Acting Injectables Producers in 2025
Table 20. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global High-Purity PLGA Polymers for Long-Acting Injectables Company Evaluation Quadrant
Table 22. World High-Purity PLGA Polymers for Long-Acting Injectables Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and High-Purity PLGA Polymers for Long-Acting Injectables Production Site of Key Manufacturer
Table 24. High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Type Footprint
Table 25. High-Purity PLGA Polymers for Long-Acting Injectables Market: Company Product Application Footprint
Table 26. High-Purity PLGA Polymers for Long-Acting Injectables Competitive Factors
Table 27. High-Purity PLGA Polymers for Long-Acting Injectables New Entrant and Capacity Expansion Plans
Table 28. High-Purity PLGA Polymers for Long-Acting Injectables Mergers & Acquisitions Activity
Table 29. United States VS China High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share (2021-2026)
Table 37. China Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share (2021-2026)
Table 42. Rest of World Based High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share (2021-2026)
Table 47. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2021-2026) & (Tons)
Table 49. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2027-2032) & (Tons)
Table 50. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2021-2026) & (USD Million)
Table 51. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2027-2032) & (USD Million)
Table 52. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2021-2026) & (US$/kg)
Table 53. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2027-2032) & (US$/kg)
Table 54. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 55. World High-Purity PLGA Polymers for Long-Acting Injectables Production by End User (2021-2026) & (Tons)
Table 56. World High-Purity PLGA Polymers for Long-Acting Injectables Production by End User (2027-2032) & (Tons)
Table 57. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User (2021-2026) & (USD Million)
Table 58. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User (2027-2032) & (USD Million)
Table 59. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2021-2026) & (US$/kg)
Table 60. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2027-2032) & (US$/kg)
Table 61. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2021-2026) & (Tons)
Table 63. World High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2027-2032) & (Tons)
Table 64. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2021-2026) & (USD Million)
Table 65. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2027-2032) & (USD Million)
Table 66. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2021-2026) & (US$/kg)
Table 67. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2027-2032) & (US$/kg)
Table 68. Evonik Industries AG Basic Information, Manufacturing Base and Competitors
Table 69. Evonik Industries AG Major Business
Table 70. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 71. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Evonik Industries AG Recent Developments/Updates
Table 73. Evonik Industries AG Competitive Strengths & Weaknesses
Table 74. Corbion N.V. Basic Information, Manufacturing Base and Competitors
Table 75. Corbion N.V. Major Business
Table 76. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 77. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Corbion N.V. Recent Developments/Updates
Table 79. Corbion N.V. Competitive Strengths & Weaknesses
Table 80. Ashland Inc. Basic Information, Manufacturing Base and Competitors
Table 81. Ashland Inc. Major Business
Table 82. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 83. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Ashland Inc. Recent Developments/Updates
Table 85. Ashland Inc. Competitive Strengths & Weaknesses
Table 86. SEQENS Basic Information, Manufacturing Base and Competitors
Table 87. SEQENS Major Business
Table 88. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 89. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. SEQENS Recent Developments/Updates
Table 91. SEQENS Competitive Strengths & Weaknesses
Table 92. Mitsui Chemicals, Inc. Basic Information, Manufacturing Base and Competitors
Table 93. Mitsui Chemicals, Inc. Major Business
Table 94. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 95. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Mitsui Chemicals, Inc. Recent Developments/Updates
Table 97. Mitsui Chemicals, Inc. Competitive Strengths & Weaknesses
Table 98. Nanjing Well Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 99. Nanjing Well Pharmaceutical Group Co., Ltd. Major Business
Table 100. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 101. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Nanjing Well Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 103. Nanjing Well Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 104. Guangzhou DiQi Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 105. Guangzhou DiQi Pharmaceuticals Co., Ltd. Major Business
Table 106. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 107. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 109. Guangzhou DiQi Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 110. Nomisma Healthcare Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 111. Nomisma Healthcare Pvt. Ltd. Major Business
Table 112. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 113. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Nomisma Healthcare Pvt. Ltd. Recent Developments/Updates
Table 115. Nomisma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
Table 116. Zhejiang Langhua Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 117. Zhejiang Langhua Pharmaceutical Co., Ltd. Major Business
Table 118. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 119. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 121. Zhejiang Langhua Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 122. Hunan Er-Kang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 123. Hunan Er-Kang Pharmaceutical Co., Ltd. Major Business
Table 124. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 125. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 127. Hunan Er-Kang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 128. Shanghai Libaimei Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 129. Shanghai Libaimei Biotechnology Co., Ltd. Major Business
Table 130. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 131. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Shanghai Libaimei Biotechnology Co., Ltd. Recent Developments/Updates
Table 133. Shanghai Libaimei Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 134. Zhejiang Bangyao Biomaterials Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 135. Zhejiang Bangyao Biomaterials Co., Ltd. Major Business
Table 136. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product and Services
Table 137. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Zhejiang Bangyao Biomaterials Co., Ltd. Recent Developments/Updates
Table 139. Zhejiang Bangyao Biomaterials Co., Ltd. Competitive Strengths & Weaknesses
Table 140. Global Key Players of High-Purity PLGA Polymers for Long-Acting Injectables Upstream (Raw Materials)
Table 141. Global High-Purity PLGA Polymers for Long-Acting Injectables Typical Customers
Table 142. High-Purity PLGA Polymers for Long-Acting Injectables Typical Distributors
LIST OF FIGURES
Figure 1. High-Purity PLGA Polymers for Long-Acting Injectables Picture
Figure 2. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 5. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price (2021-2032) & (US$/kg)
Figure 6. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region (2021-2032)
Figure 7. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2032)
Figure 8. North America High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 9. Europe High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 10. China High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 11. Japan High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 12. India High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 13. Southeast Asia High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 14. High-Purity PLGA Polymers for Long-Acting Injectables Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 17. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Region (2021-2032)
Figure 18. United States High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 19. China High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 20. Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 21. Japan High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 22. South Korea High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 23. ASEAN High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 24. India High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 25. Producer Shipments of High-Purity PLGA Polymers for Long-Acting Injectables by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for High-Purity PLGA Polymers for Long-Acting Injectables Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for High-Purity PLGA Polymers for Long-Acting Injectables Markets in 2025
Figure 28. United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share 2025
Figure 32. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share 2025
Figure 33. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share 2025
Figure 34. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type in 2025
Figure 36. PLGA 50:50
Figure 37. PLGA 75:25
Figure 38. PLGA 85:15
Figure 39. Other Ratios and Customized PLGA
Figure 40. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Type (2021-2032)
Figure 41. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type (2021-2032)
Figure 42. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2021-2032) & (US$/kg)
Figure 43. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 44. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by End User in 2025
Figure 45. Pharmaceutical Companies and Marketing Authorization Holders
Figure 46. Formulation CDMOs and Drug Delivery Development Service Providers
Figure 47. Research Institutions and Translational R&D Platforms
Figure 48. Other End Users
Figure 49. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by End User (2021-2032)
Figure 50. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by End User (2021-2032)
Figure 51. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2021-2032) & (US$/kg)
Figure 52. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application in 2025
Figure 54. Sustained-release Microspheres
Figure 55. In-situ Forming Depot Systems
Figure 56. Biodegradable Drug-eluting Implants
Figure 57. Nanoparticle Drug Delivery Systems
Figure 58. Other Parenteral Controlled-release Applications
Figure 59. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Application (2021-2032)
Figure 60. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application (2021-2032)
Figure 61. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2021-2032) & (US$/kg)
Figure 62. High-Purity PLGA Polymers for Long-Acting Injectables Industry Chain
Figure 63. High-Purity PLGA Polymers for Long-Acting Injectables Procurement Model
Figure 64. High-Purity PLGA Polymers for Long-Acting Injectables Sales Model
Figure 65. High-Purity PLGA Polymers for Long-Acting Injectables Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
Figure 1. High-Purity PLGA Polymers for Long-Acting Injectables Picture
Figure 2. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 5. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price (2021-2032) & (US$/kg)
Figure 6. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region (2021-2032)
Figure 7. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2032)
Figure 8. North America High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 9. Europe High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 10. China High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 11. Japan High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 12. India High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 13. Southeast Asia High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (Tons)
Figure 14. High-Purity PLGA Polymers for Long-Acting Injectables Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 17. World High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Region (2021-2032)
Figure 18. United States High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 19. China High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 20. Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 21. Japan High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 22. South Korea High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 23. ASEAN High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 24. India High-Purity PLGA Polymers for Long-Acting Injectables Consumption (2021-2032) & (Tons)
Figure 25. Producer Shipments of High-Purity PLGA Polymers for Long-Acting Injectables by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for High-Purity PLGA Polymers for Long-Acting Injectables Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for High-Purity PLGA Polymers for Long-Acting Injectables Markets in 2025
Figure 28. United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share 2025
Figure 32. China Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share 2025
Figure 33. Rest of World Based Manufacturers High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share 2025
Figure 34. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type in 2025
Figure 36. PLGA 50:50
Figure 37. PLGA 75:25
Figure 38. PLGA 85:15
Figure 39. Other Ratios and Customized PLGA
Figure 40. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Type (2021-2032)
Figure 41. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type (2021-2032)
Figure 42. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Type (2021-2032) & (US$/kg)
Figure 43. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 44. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by End User in 2025
Figure 45. Pharmaceutical Companies and Marketing Authorization Holders
Figure 46. Formulation CDMOs and Drug Delivery Development Service Providers
Figure 47. Research Institutions and Translational R&D Platforms
Figure 48. Other End Users
Figure 49. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by End User (2021-2032)
Figure 50. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by End User (2021-2032)
Figure 51. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by End User (2021-2032) & (US$/kg)
Figure 52. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application in 2025
Figure 54. Sustained-release Microspheres
Figure 55. In-situ Forming Depot Systems
Figure 56. Biodegradable Drug-eluting Implants
Figure 57. Nanoparticle Drug Delivery Systems
Figure 58. Other Parenteral Controlled-release Applications
Figure 59. World High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Application (2021-2032)
Figure 60. World High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application (2021-2032)
Figure 61. World High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Application (2021-2032) & (US$/kg)
Figure 62. High-Purity PLGA Polymers for Long-Acting Injectables Industry Chain
Figure 63. High-Purity PLGA Polymers for Long-Acting Injectables Procurement Model
Figure 64. High-Purity PLGA Polymers for Long-Acting Injectables Sales Model
Figure 65. High-Purity PLGA Polymers for Long-Acting Injectables Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
